Drug Profile
ONO 2333Ms
Alternative Names: ONO-2333MsLatest Information Update: 17 Feb 2009
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Antidepressants; Anxiolytics
- Mechanism of Action Corticotropin releasing factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 31 Mar 2005 Phase-I clinical trials in Anxiety disorders in USA (PO)
- 31 Mar 2005 Phase-I clinical trials in Depression in USA (PO)